Dr PERANI Angelo

Dedicated and accomplished Biotechnology Executive with extensive experience in leading scientific research and development projects. Adept at driving innovation, streamlining processes, and ensuring compliance with regulatory standards. Proven track record of success in overseeing the production of biosimilars, developing intellectual property strategies, and fostering a culture of innovation.

• Cicada Innovations / Jumar Bio Incubator, Melbourne, Australia, Independent member of the IBC (Part-time), Provided expert advice ensuring compliance with regulatory obligations, contributing to the successful operation of Jumar Bio.
• Me@ biotech, Melbourne, Australia, Principal Scientist / Cell Line development (Part-time), Instrumental in developing and implementing the company's IP strategy, resulting in streamlined operations and increased efficiency. Established GLP programs and project management platforms, enhancing research and development processes.
• NeuClone, Sydney Australia, Chief Scientific Officer, 2015 - 2022, Led the design and production of over 20 biosimilars, successfully completing Phase I Clinical Trials for NeuCeptin and NeuLara. Pioneered innovative strategies to acquire cutting-edge technology, maintaining NeuClone's competitive advantage in the biosimilar landscape.
• FB-Rice, Melbourne - Sydney Australia, Technical Expert Advisor on Patent Opposition Matters, 2014 - 2016, Provided expert guidance on patent opposition matters, ensuring the protection of intellectual property rights.
• Ludwig Institute for Cancer Research - ONJCRI, Melbourne Australia, Head of the Cell Biology Group and Facility Manager of the Mammalian Protein Expression Facility, 2007 - 2014, Generated over 30 stable cell lines for oncology targets, significantly increasing throughput and production yields. Spearheaded the development of methods for detecting apoptosis and isolating glycosylated receptors, contributing to groundbreaking research in cancer biology.
• Ludwig Institute for Cancer Research, Melbourne Australia, Head of the Biologic Production Facility, 2004 - 2007, Directed the production of monoclonal antibodies and recombinant proteins, ensuring compliance with regulatory standards.
• Lonza Biologics, Slough UK, Senior Research Scientist, Co-inventor on 1 Lonza patent, and led protein production optimization activities.